Expres2ion Biotech Hldg Stock Total Debt
| 5JD Stock | EUR 1.77 0.06 3.28% |
EXPRES2ION BIOTECH HLDG fundamentals help investors to digest information that contributes to EXPRES2ION BIOTECH's financial success or failures. It also enables traders to predict the movement of EXPRES2ION Stock. The fundamental analysis module provides a way to measure EXPRES2ION BIOTECH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EXPRES2ION BIOTECH stock.
EXPRES2ION |
EXPRES2ION BIOTECH HLDG Company Total Debt Analysis
EXPRES2ION BIOTECH's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, EXPRES2ION BIOTECH HLDG has a Total Debt of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The total debt for all Germany stocks is 100.0% higher than that of the company.
EXPRES2ION Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EXPRES2ION BIOTECH's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EXPRES2ION BIOTECH could also be used in its relative valuation, which is a method of valuing EXPRES2ION BIOTECH by comparing valuation metrics of similar companies.EXPRES2ION BIOTECH is currently under evaluation in total debt category among its peers.
EXPRES2ION Fundamentals
| Return On Equity | -0.57 | |||
| Return On Asset | -0.34 | |||
| Shares Outstanding | 37.15 M | |||
| Shares Owned By Institutions | 1.71 % | |||
| Gross Profit | 6.22 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 12.79 X | |||
| Number Of Employees | 27 | |||
| Beta | 1.46 | |||
| Market Capitalization | 44 M |
About EXPRES2ION BIOTECH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EXPRES2ION BIOTECH HLDG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EXPRES2ION BIOTECH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EXPRES2ION BIOTECH HLDG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in EXPRES2ION Stock
EXPRES2ION BIOTECH financial ratios help investors to determine whether EXPRES2ION Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EXPRES2ION with respect to the benefits of owning EXPRES2ION BIOTECH security.